More recently, anti-ERα rabid monoclonal antibody SP1—which recognizes C-terminal of ERα—has been introduced and is reported to have higher sensitivity and an 8-fold higher affinity in breast carcinomas for the detection of ERα, compared with ID5 [42]. This evidence concerns the gene ESR1 and breast carcinoma.